Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 144


TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).

Bunch B, Krishnan N, Greenspan RD, Ramakrishnan S, Attwood K, Yan L, Qi Q, Wang D, Morrison C, Omilian A, Bshara W, Pili R, Trump DL, Johnson C, Woloszynska A.

Cell Cycle. 2019 Sep;18(17):2055-2066. doi: 10.1080/15384101.2019.1638693. Epub 2019 Jul 18.


Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.

Bunch BL, Ma Y, Attwood K, Amable L, Luo W, Morrison C, Guru KA, Woloszynska-Read A, Hershberger PA, Trump DL, Johnson CS.

Cancer Med. 2019 May;8(5):2449-2461. doi: 10.1002/cam4.2119. Epub 2019 Apr 10.


Calcitriol and cancer therapy: A missed opportunity.

Trump DL.

Bone Rep. 2018 Jun 13;9:110-119. doi: 10.1016/j.bonr.2018.06.002. eCollection 2018 Dec.


Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.

McDonnell SL, Baggerly CA, French CB, Baggerly LL, Garland CF, Gorham ED, Hollis BW, Trump DL, Lappe JM.

PLoS One. 2018 Jun 15;13(6):e0199265. doi: 10.1371/journal.pone.0199265. eCollection 2018.


Vitamin D in prostate cancer.

Trump DL, Aragon-Ching JB.

Asian J Androl. 2018 May-Jun;20(3):244-252. doi: 10.4103/aja.aja_14_18. Review.


Vitamin D Receptor Signaling and Cancer.

Campbell MJ, Trump DL.

Endocrinol Metab Clin North Am. 2017 Dec;46(4):1009-1038. doi: 10.1016/j.ecl.2017.07.007. Epub 2017 Sep 29. Review.


1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.

Ma Y, Luo W, Bunch BL, Pratt RN, Trump DL, Johnson CS.

Oncotarget. 2017 Jul 27;8(36):60080-60093. doi: 10.18632/oncotarget.19629. eCollection 2017 Sep 1.


Targeted therapies in the treatment of urothelial cancers.

Aragon-Ching JB, Trump DL.

Urol Oncol. 2017 Jul;35(7):465-472. doi: 10.1016/j.urolonc.2017.03.011. Epub 2017 Mar 31. Review.


Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing.

Wei L, Papanicolau-Sengos A, Liu S, Wang J, Conroy JM, Glenn ST, Brese E, Hu Q, Miles KM, Burgher B, Qin M, Head K, Omilian AR, Bshara W, Krolewski J, Trump DL, Johnson CS, Morrison CD.

BMC Med Genomics. 2016 Oct 19;9(1):64.


Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.

Hinata N, Hussein AA, George S, Trump DL, Levine EG, Omar K, Dasgupta P, Khan MS, Hosseini A, Wiklund P, Guru KA.

BJU Int. 2017 Apr;119(4):605-611. doi: 10.1111/bju.13678. Epub 2016 Nov 18.


Systemic therapy in muscle-invasive and metastatic bladder cancer: current trends and future promises.

Aragon-Ching JB, Trump DL.

Future Oncol. 2016 Sep;12(17):2049-58. doi: 10.2217/fon-2016-0155. Epub 2016 Jun 16. Review.


Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib.

Wei L, Liu S, Conroy J, Wang J, Papanicolau-Sengos A, Glenn ST, Murakami M, Liu L, Hu Q, Conroy J, Miles KM, Nowak DE, Liu B, Qin M, Bshara W, Omilian AR, Head K, Bianchi M, Burgher B, Darlak C, Kane J, Merzianu M, Cheney R, Fabiano A, Salerno K, Talati C, Khushalani NI, Trump DL, Johnson CS, Morrison CD.

Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000380. doi: 10.1101/mcs.a000380.


The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer.

Cannon TL, Ford J, Hester D, Trump DL.

Case Rep Pancreat Cancer. 2016 May 1;2(1):32-35. doi: 10.1089/crpc.2016.0003. eCollection 2016.


Vitamin D Signaling Modulators in Cancer Therapy.

Luo W, Johnson CS, Trump DL.

Vitam Horm. 2016;100:433-72. doi: 10.1016/bs.vh.2015.11.004. Epub 2016 Jan 13.


Mechanistic Insights of Vitamin D Anticancer Effects.

Ma Y, Johnson CS, Trump DL.

Vitam Horm. 2016;100:395-431. doi: 10.1016/bs.vh.2015.11.003. Epub 2016 Jan 13. Review.


Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.

Yao S, Haddad SA, Hu Q, Liu S, Lunetta KL, Ruiz-Narvaez EA, Hong CC, Zhu Q, Sucheston-Campbell L, Cheng TY, Bensen JT, Johnson CS, Trump DL, Haiman CA, Olshan AF, Palmer JR, Ambrosone CB.

Int J Cancer. 2016 May 1;138(9):2118-26. doi: 10.1002/ijc.29954. Epub 2015 Dec 28.


Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.

Pokuri VK, Syed JR, Yang Z, Field EP, Cyriac S, Pili R, Levine EG, Azabdaftari G, Trump DL, Guru K, George S.

Clin Genitourin Cancer. 2016 Feb;14(1):e59-65. doi: 10.1016/j.clgc.2015.09.013. Epub 2015 Oct 3.


Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model.

Mazzilli SA, Hershberger PA, Reid ME, Bogner PN, Atwood K, Trump DL, Johnson CS.

Cancer Prev Res (Phila). 2015 Oct;8(10):895-904. doi: 10.1158/1940-6207.CAPR-14-0403. Epub 2015 Aug 14.


Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP.

Steck SE, Arab L, Zhang H, Bensen JT, Fontham ET, Johnson CS, Mohler JL, Smith GJ, Su JL, Trump DL, Woloszynska-Read A.

PLoS One. 2015 Apr 28;10(4):e0125151. doi: 10.1371/journal.pone.0125151. eCollection 2015.


Structural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectives.

Liu B, Conroy JM, Morrison CD, Odunsi AO, Qin M, Wei L, Trump DL, Johnson CS, Liu S, Wang J.

Oncotarget. 2015 Mar 20;6(8):5477-89. Review.

Supplemental Content

Loading ...
Support Center